Literature DB >> 14671308

A muscleblind knockout model for myotonic dystrophy.

Rahul N Kanadia1, Karen A Johnstone, Ami Mankodi, Codrin Lungu, Charles A Thornton, Douglas Esson, Adrian M Timmers, William W Hauswirth, Maurice S Swanson.   

Abstract

The neuromuscular disease myotonic dystrophy (DM) is caused by microsatellite repeat expansions at two different genomic loci. Mutant DM transcripts are retained in the nucleus together with the muscleblind (Mbnl) proteins, and these abnormal RNAs somehow interfere with pre-mRNA splicing regulation. Here, we show that disruption of the mouse Mbnl1 gene leads to muscle, eye, and RNA splicing abnormalities that are characteristic of DM disease. Our results support the hypothesis that manifestations of DM can result from sequestration of specific RNA binding proteins by a repetitive element expansion in a mutant RNA.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14671308     DOI: 10.1126/science.1088583

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  349 in total

1.  Cancer risk among patients with myotonic muscular dystrophy.

Authors:  Shahinaz M Gadalla; Marie Lund; Ruth M Pfeiffer; Sanne Gørtz; Christine M Mueller; Richard T Moxley; Sigurdur Y Kristinsson; Magnus Björkholm; Fatma M Shebl; James E Hilbert; Ola Landgren; Jan Wohlfahrt; Mads Melbye; Mark H Greene
Journal:  JAMA       Date:  2011-12-14       Impact factor: 56.272

2.  RNA steady-state defects in myotonic dystrophy are linked to nuclear exclusion of SHARP.

Authors:  Warunee Dansithong; Sonali P Jog; Sharan Paul; Robabeh Mohammadzadeh; Stephanie Tring; Yukwah Kwok; Rebecca C Fry; Paul Marjoram; Lucio Comai; Sita Reddy
Journal:  EMBO Rep       Date:  2011-07-01       Impact factor: 8.807

3.  Muscle weakness in myotonic dystrophy associated with misregulated splicing and altered gating of Ca(V)1.1 calcium channel.

Authors:  Zhen Zhi Tang; Viktor Yarotskyy; Lan Wei; Krzysztof Sobczak; Masayuki Nakamori; Katy Eichinger; Richard T Moxley; Robert T Dirksen; Charles A Thornton
Journal:  Hum Mol Genet       Date:  2011-12-02       Impact factor: 6.150

Review 4.  Neurodegeneration the RNA way.

Authors:  Abigail J Renoux; Peter K Todd
Journal:  Prog Neurobiol       Date:  2011-11-03       Impact factor: 11.685

Review 5.  RNA-binding proteins in microsatellite expansion disorders: mediators of RNA toxicity.

Authors:  Gloria V Echeverria; Thomas A Cooper
Journal:  Brain Res       Date:  2012-02-22       Impact factor: 3.252

Review 6.  Animal models of muscular dystrophy.

Authors:  Rainer Ng; Glen B Banks; John K Hall; Lindsey A Muir; Julian N Ramos; Jacqueline Wicki; Guy L Odom; Patryk Konieczny; Jane Seto; Joel R Chamberlain; Jeffrey S Chamberlain
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

7.  Solution structure of the RNA binding domain in the human muscleblind-like protein 2.

Authors:  Fahu He; Weirong Dang; Chikage Abe; Kengo Tsuda; Makoto Inoue; Satoru Watanabe; Naohiro Kobayashi; Takanori Kigawa; Takayoshi Matsuda; Takashi Yabuki; Masaaki Aoki; Eiko Seki; Takushi Harada; Yuri Tomabechi; Takaho Terada; Mikako Shirouzu; Akiko Tanaka; Peter Güntert; Yutaka Muto; Shigeyuki Yokoyama
Journal:  Protein Sci       Date:  2009-01       Impact factor: 6.725

8.  Dystrophia myotonia: why focus on foci?

Authors:  R P Junghans
Journal:  Eur J Hum Genet       Date:  2009-01-28       Impact factor: 4.246

Review 9.  The Role of RNA in Biological Phase Separations.

Authors:  Marta M Fay; Paul J Anderson
Journal:  J Mol Biol       Date:  2018-05-10       Impact factor: 5.469

10.  A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart.

Authors:  Auinash Kalsotra; Xinshu Xiao; Amanda J Ward; John C Castle; Jason M Johnson; Christopher B Burge; Thomas A Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.